Epoprostenol
is a prostaglandin (a hormone-like actuality that occurs by itself in the
body). Prostaglandins advice to ascendancy functions in the physique such as
claret burden and beef contractions.
Epoprostenol
is an intravenous medication accustomed for the analysis of pulmonary arterial
hypertension (PAH) in World Health Organization (WHO) Group 1 patients.
Epoprostenol is a constructed alternation of prostacyclin, a by itself
occurring actuality in the body, which has furnishings on dilating claret
vessels. Epoprostenol was accustomed for PAH by the United States Food and Drug
Administering (FDA) in 1995.
The
above accomplishments of epoprostenol are vasodilatation of the pulmonary and
systemic vascular beds (widening of narrowed claret argosy in the lung and
added locations of the body), and inhibition of platelet clumping
(aggregation). Bigger adaptation and exercise accommodation has been approved
in a 3-month extraction of intravenous epoprostenol accustomed to patients with
idiopathic pulmonary arterial hypertension.
An
added balloon with intravenous epoprostenol included administering to patients
with PAH associated with the scleroderma spectrum of affiliation tissue
disease. This resulted in bargain affection and bigger exercise accommodation
in patients.
没有评论:
发表评论